VALENCIA, Calif., Dec. 2 /PRNewswire/ -- The Alfred E. Mann Foundation for Biomedical Engineering (AEMFBE), a philanthropic organization created by billionaire Alfred E. Mann to establish university-based commercialization- enablement institutes at elite universities, designed to facilitate biomedical product development for the benefit of society, today announced the launch of a Web site (http://www.mannfbe.org).
Features of the web site include:
-- Overview of Alfred Mann Institutes for Biomedical Development (AMIs),
including the infrastructure and process that are created by the minimum of
$100 million endowment to establish each Institute. To date, three Alfred
Mann Institutes have been endowed:
-- Background and accomplishments of Mr. Mann, who has dedicated most of his career to bettering the quality of life for those who suffer from life debilitating disorders through the development of innovative medical devices.
-- "Commercialize Your Idea," which provides insight into the developmental steps for a biomedical technology including proof of concept, FDA regulatory approval, reimbursement strategies, technology licensing considerations, etc., with an emphasis toward researchers involved in this space.
"The AMI concept has drawn a phenomenal response, both nationally and internationally, as a new model for technology transfer, a form of venture philanthropy," said A. Stephen Dahms, Ph.D., President and CEO of the AEMFBE. "The Web site addresses researchers' frequently asked questions and provides an overview of the AMI selection and creation process."
About Alfred Mann
Alfred Mann's philanthropic mission is to create and expedite the delivery
of life-improving biomedical products to patients. Mann is chairman of the
boards of directors for the Alfred Mann Institutes for Biomedical Development
About the Mann Foundation for Biomedical Engineering
Headquartered in the 167-acre Mann Biomedical Park in Valencia, Calif., the Alfred Mann Foundation for Biomedical Engineering (AEMFBE) is a philanthropic organization that establishes university-based institutes (AMIs) designed to enable biomedical product development for the benefit of mankind. The AEMFBE supports the AMIs with a variety of services, including market analysis and due diligence, valuation and exit strategy, regulatory and reimbursement guidance, cost of goods analysis and other product development activities required to expedite technologies from development to commercialization.
Contact: Nancy Patterson Vice President 626-993-4106 Nancy.email@example.com
|SOURCE Alfred E. Mann Foundation for Biomedical Engineering|
Copyright©2008 PR Newswire.
All rights reserved